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Abstract The properties of colicin S8 are diﬀerent for
the cytoplasmic, periplasmic and extracellular protein.
Interactions with its speciﬁc receptors reﬂect this. Active
cell extracts separate into a non-anionic along with an
anionic fraction by DEAE-Sephacell chromatography.
Previously, we have puriﬁed cell-associated colicin S8 as
an aggregation of highly related polypeptides; cyto-
plasmic colicin S8 seems to be post-translationally pro-
cessed into an aggregation of polypeptides of molecular
mass ranging from 45,000 Da to 60,000 Da. We suggest
that a conformational change to colicin S8 may occur
related to the export process.
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Introduction
Colicin S8, a bacteriocin, is synthesized when Escheri-
chia coli cells harboring Col S8 plasmid are treated
with agents such as mitomycin C or ultraviolet light [8,
26]. The protein thus synthesized is exported across
both inner and outer membranes and released into the
medium [25]. Colicins do not contain a signal sequence
and their release is allowed by colicin lysis proteins [5],
which might use the general export pathway of the cell
that uses signal peptides to direct proteins to the cell
envelope [25]. These proteins increase envelope perme-
ability, and colicins are released from colicinogenic cells
as water-soluble polypeptides [3]. However, in order to
be transferred across a membrane, a soluble protein
might alter its shape to suit distinct cell environments.
There are reports of multiple forms of colicins.
For example, colicins K [10] and V [15] were puriﬁed as
a complex of protein with bacterial antigen O. More
recently, colicins A, E1 and Ia [13, 14, 19] have
been found in vitro in at least two diﬀerent membrane-
associated states. In addition, it has been suggested
that multiple contacts with periplasmic-exposed
Tol proteins is a prerequisite for group A colicin
translocation [13]. Thus, the existence of colicins in
more than one conformation seems to be a common
phenomenon.
Colicins that are members of the ion-channel-
forming family of colicins [17] are proteins that un-
dergo a transition from soluble to transmembrane
conﬁguration. In fact, a conformational change has
been proposed for colicin A upon release from the
cytoplasm to the medium [14]. Channel-forming colic-
ins undergo a remarkable series of conformational
gyrations during their journey from the extracellular
milieu to the periplasmic membrane [11]. Conforma-
tional changes of the same sort have been demon-
strated for the alfa-toxin of Staphylococcus aureus,
which, like colicin A, can form channels in biological
membranes [20]. An improved model for pore-forming
colicin import proposes unfolding of the colicin initi-
ated very early in the translocation process by its
binding to the receptor [7].
We previously reported puriﬁcation of the colicin S8
that remains cell-associated after induction of producing
cells [4], and demonstrated that at least two electrone-
gatively diﬀerent proteins with colicin activity exist, both
being composed of extremely related polypeptides. The
experiments presented here suggest a diﬀerence in con-
formation between cytoplasmic, periplasmic and extra-
cellular colicin S8. We suggest that a conformational
change of colicin S8 might be involved in the export of
colicin S8. Thus, our previous ﬁnding that colicin S8
exists as an aggregation of polypeptides could be of
physiological signiﬁcance.
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Materials and methods
Preparation of colicin active fractions
E. coli K-12 VE831 [8] was used as an indicator strain and for
control experiments, and VE832 (VE831 containing pColS8) was
used as a source for colicin. Bacteria were grown at 37C in LB
medium [21]. Where appropriate, colicin detection was in solid
medium. For colicin production, growth was carried out with high-
speed rotational shaking during incubation using 2-l ﬂattened
ﬂasks of 25 cm bottom diameter containing 1-l culture. Induction
was at an absorbance of 0.4 at 600 nm, with mitomycin C added at
0.4 lg/ml (ﬁnal concentration). Induced cells were harvested by
centrifugation (6,000 g for 10 min) from 1 l cultures. After resu-
spending in 200 ml washing buﬀer (0.01 M Tris-HCl pH 8.0) the
cells were gently shaking for 3 h at 37 C in the dark. Cells were
again harvested, and the supernatant saved as ML (wash). Cold-
shock treatment was as follows: pelleted cells were resuspended (at
40 ml/g bacteria) in 0.05 M EDTA, 20% saccharose, 0.03 M Tris-
HCl, pH 7 buﬀer. After incubation at room temperature for
15 min and centrifugation, cells were immediately treated with 1:1
(v/v) 0.5 mM MgCl2 at 0C for 15 min. Cells were pelleted,
supernatant was saved, cold shock treatment repeated once and
supernatants pooled and saved at )20C as CS (cold-shock) (this
protocol was obtained from P. Garcia in our laboratory). Finally,
cells were resuspended in 100 ml 0.01 M Tris-HCl pH 8 and son-
icated for three intervals of 60 s using an MSE probe sonicator.
Absorbance was reduced to 10%. Cellular debris was separated by
centrifugation at 5,000 g for 15 min and the supernatant was
sterilized with chloroform and saved as SON (sonicate). Frozen
SON ()20C) remained active for several months. A cocktail of
protease inhibitors: 10 mM leupeptin, 50 mM phenylmethylsul-
fonyl ﬂuoride and 100 mM N-a-p-tosyl-L-lysine chloromethyl
ketone (Sigma, St. Louis. Mo.) was used in all preparations.
Titration and chromatography
Stab test, quantitative and qualitative titers were carried out as
described previously [9]. Internal colicin was tested with strain
BCM97 [8].
Chromatographic separation on DEAE-Sephacell column
DEAE-Sephacell (10·200 mm, Pharmacia) was equilibrated with
20 mM Tris-HCl, pH 8.0 buﬀer and loaded with colicin active
fractions. After elution, a 0–1 M NaCl gradient was applied
(continuously or discontinuously) to the column at 30 ml/h at 4C.
The eﬄuent was monitored by the absorbance at 280 nm using a
UV-M detector.
Resistant isogenic strains isolation
E. coli K12 C600, C10 strain from Na´gel de Zwa´ig [22] was used. It
was laid over stabs of producing colicin strain BS81a [8] and also
over spots of several colicin active fractions. After 24 or 48 h,
colonies growing within growth inhibition ‘‘halos’’ were picked up,
puriﬁed and tested for both T6 bacteriophage and colicin K resis-
tance. Those isolates showing no ‘‘halo’’ and sensitivity to T6
bacteriophage were classiﬁed as ‘‘tolerant’’ [23] while no ‘‘halo’’
and T6 resistance corresponded to ‘‘resistant’’.
Statistical analysis
Cluster analysis with Euclidean relative distance and group average
linkage was used for displaying homogeneous groups and the dif-
ferences between them [12]. TWINSPAN, a FORTRAM program
to arrange multivariate data in an ordered two-way table by clas-
siﬁcation of the individuals and their attributes. This analysis was
performed by M. Farin˜as, at the ICAE (Instituto de Ciencias
Ambientales y Ecolo´gicas, Venezuela).
Maxicell experiments
Maxicells were prepared using the method of Sancar et al. [24].
Strains were colS8::Tn3 mutants obtained as described by Garcia
and Dyke [8].
Results and discussion
Induction and release of colicin S8
We have shown before [4] that, under the conditions
used, optimum induction of colicin S8 is obtained fol-
lowing 60 s exposure to UV-irradiation or addition of
mitomycin C (0.4 lg/ml). Once the cells are induced and
incubated in the dark at 37C, production proceeds at
nearly the same rate for at least 3 h. Under these con-
ditions, the culture supernatant contained 42% of the
total colicin produced (Table 1). A signiﬁcant amount
remained cell-associated (58%), as was determined after
sonication of the cells. Most (26%) of the cell-associated
colicin could be released by cold-shock treatment com-
pared to 16% released previously by washing the cells.
These results indicate that colicin S8 has a periplasmic
stage on its way out of the cell. When these cells were
sonicated, we found that a small amount of colicin S8
had remained inside (16%).
Chromatographic separation on a DEAE-Sephacell
column
Colicin S8 active fractions from diﬀerent cell compart-
ments can be separated into two major activity peaks
after cationic exchange chromatography (Fig. 1). The
ﬁrst active fraction did not associate with the DEAE-
Sephacell matrix and thus eluted with the elution buﬀer.
This fraction appears to predominate in ML, where there
is 10 times the amount present in SON and 100 times that
in CS. In fact, it predominates in SON if we consider the
origin of the ML fraction: induced cells continuously
producing for 3 h. The second active fraction was eluted
from the column in the presence of 0.2 M NaCl. Most of
it is present in ML and CS preparations, as only a
residual 10% was detected in SON. Both fractions, ML
and CS, could contain the colicin released from the
cytoplasm. The non-anionic colicin (eluted with the elu-
tion buﬀer) must be the synthesized colicin S8 as it is the
main component in the SON fraction.
Biological heterogeneity of active fractions
Colicin S8 shares receptors with colicin K and T6 [1]. We
selected some resistant isogenic isolates (see Materials
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and methods) that showed three types of behavior: ‘‘no
halo’’, ‘‘turbid halo’’ and ‘‘half turbid-half transparent
halo’’. The ‘‘no halo’’ phenotype could correspond to
resistance (no receptors) or tolerance (receptors but no
uptake system to enter the external membrane). Thus,
speciﬁc surface receptors and speciﬁc components of the
uptake system used by colicin S8 must be modiﬁed in
order to respond diﬀerently to colicin S8 active fractions.
Cellular subfractions obtained after chromatographic
separation in DEAE-Sephacell were tested for their
activity against a selection of 17 strains from the resis-
tant isogenic isolates. Subfractions and isolates were
sorted out by a cluster analysis according to similarities
in their response. Isolates fall into three diﬀerent pat-
terns of behavior. The ﬁrst type of response is shown by
those isolates reacting similarly to subfractions from ML
and CS: type 1. CS and SON show a diﬀerent type of
response: type 2. There is a third group of isolates
showing a mixture of these two patterns: type 1-2. This
mixed type 1-2 is probably due to some colicin remain-
ing on the surface after cold shock treatment. Isolates
could be classiﬁed into two major groups when a den-
drogram was produced using these data (Fig. 2): group I
looks more homogeneous and is composed of isolates
characterized as type 1 and type 1-2, and group II is
composed of isolates of type 2. These results suggest one
predominant conformation of colicin S8 in ML and CS
fractions (exported colicin), with another conformation
present in SON (cytoplasmic colicin). These two con-
formations would diﬀer in electrical charge. In addition,
our results indicate that colicin S8 is active prior to
export.
Table 1 Colicin S8 activity
distribution in cell fractions.
ML Wash fraction,CS cold-
shock fraction, SON sonicate
fraction
Fraction Volume
(ml)
Total proteins
(mg)
Colicin activity
(total U)
Speciﬁc
activity
Total colicin
produced (%)
Supernatant 1,000 1,920 4.74·1012 2.4·108 42
ML 100 5,200 1.82·1012 3.5·108 16
CS 100 3,400 2.96·1012 8.7·108 26
SON 100 5,700 1.82·1012 3.2·108 16
Fig. 1A–C Cationic exchange chromatography of colicin S8 active
fractions. Colicin active fractions obtained from cellular cultures
were each loaded onto a DEAE-Sephacell column and eluted ﬁrst
with buﬀer and then with a discontinuous 0–1 M NaCl gradient. A
ML (wash), B CS (cold-shock), and C SON (sonicate). Colicin
activity is given in arbitrary units according to the qualitative test
described elsewhere [9]
Fig. 2 Dendrogram of subfractions according to their activity
towards resistant isogenic strains. Colicin active subfractions
collected from the cationic exchange chromatography of colicin
S8 active fractions were tested against 17 independently isolated
resistant strains. A relative euclidean, group average dendrogram
of subfractions was constructed. Group I is composed of type 1
and type 1-2 isolates, and group II of type 2 isolates. ML Wash
fraction, CS cold-shock fraction, SN sonicate fraction (see text).
NaCl concentration: 0 0 M, 005 0.05 M, 008 0.08 M, 01 0.1 M,
02 0.2 M, 04 0.4 M, 08 0.8 M
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Activity of the internal colicin
Mutant BCM97 synthesizes some colicin but does not
release it, as it is probably a lysis-deﬁcient mutant (lys)),
according to the insertion location on the genetic map of
pColS8 [8]. After long incubation with chloroform, a
‘‘halo’’ of colicin activity is observed (Me´ndez Ivonne,
personal communication), indicating that chloroform
has allowed the internal colicin to leave the cell, and
that this colicin is totally active (Table 2). Thus,
conformational change is not a requirement for colicin
S8 activity.
Polypeptides synthesized by the pColS8 plasmid
Minicell preparations of colicin-producing plasmids give
a 60 kDa band on SDS-PAGE whereas colicin-deﬁcient
mutants do not [8]. A similar experiment was carried out
using the maxicell expression system (Fig. 3). The ColS8
DNA expressed several polypeptides of 60, 50, 48 and
45 kDa while ColS8::Tn1 mutants failed to produce any
of these. In fact, maxicells and minicells are diﬀerent
expression systems. Two notable properties of maxicells
are the absence of the cell wall and the presence of the
chromosome along with the plasmid. As in minicells,
there is one only replicon: the plasmid. We conclude
that: (1) the 50, 48 and 45 kDa polypeptides are post-
translational products of the 60 kDa polypeptide, and
(2) minicells cannot process the 60 kDa polypeptide
because of chromosomal and/or cytoplasmic factors that
are either missing or not concentrated enough.
In a previous study [4] we puriﬁed colicin S8 as an
aggregation of highly related polypeptides of molecular
mass ranging from 47,000 Da to 63,000 Da. In the
present article we propose that colicin S8 is synthesized
as a polypeptide of about 56,000 Da, and that it is active
on the membrane in a dimeric form (110,000 Da) and
then modiﬁed (speciﬁcally or unspeciﬁcally) by proteol-
ysis, multimer formation and/or conformational chan-
ges. We propose either that colicin S8 is synthesized as
an active protein and undergoes a conformational
change upon release to the medium, or that it is specif-
ically modiﬁed inside the cytoplasm to produce export-
able colicin S8.
In the ﬁrst case, a model has been presented regarding
colicin A [16], a monomer with hydrophilic residues
exposed on the molecule surface turning partly inside
out before forming dimers with the hydrophobic resi-
dues on the outer surface of cytoplasmic colicin.
Extracellular colicin does not form dimers. Our second
suggestion is that a conformational/structural change
may be caused by processing of cytoplasmic colicin S8.
Diﬀerences in the export mechanism could form the
basis for this model. In contrast to colicins, which diﬀer
widely in their structure and mode of action, colicin lysis
proteins are highly homologous in gene organization,
primary structure and function [18]. However, some
diﬀerences have been shown between two lysis proteins:
CalE1 (colicin E1 lysis protein) and CelA (colicin A lysis
protein) [2]. CelA is strongly dependent on both the
SecA and the SecY (PrlA) proteins for its own export
and for promoting export of other proteins, whereas Cal
seems to be less dependent upon these two proteins.
Thus, diﬀerences in the mechanism of colicin export may
be related to conformational structural changes of the
colicin molecule. The change may be similar in nature to
the unfolding of colicin A during its translocation into
the cell [6]. Our proposal here is that there is a diﬀerence
between cytoplasmic and extracellular colicin S8, and
that that diﬀerence could be of physiological signiﬁ-
cance.
Table 2 Activity of internal and external colicin S8 upon incuba-
tion with chloroform for the times indicated
pColS8 Inhibition ‘‘halo’’
5 min 10 min 15 min 20 min
col+, lys+, imm+a + + + +
col+, lys), imm+b ) ) ) +
aStrain VE832 containing a wild type colS8 plasmid (see Materials
and methods)
bBCM97 containing a lysis defective plasmid (see Materials and
methods)
Fig. 3 Polypeptides synthesized by pColS8 in maxicell prepara-
tions. Maxicells were prepared and labeled using the method of
Sancar et al. [24]. SDS-polyacrylamide gels were prepared
according to Tyler and Sherratt [26]. Lanes: 1 Polypeptides
synthesized in a maxicell preparation by wt pColS8, 2–7 mutant
hybrid plasmids obtained in Garcia and Dyke [8]: col+, imm+, Apr
mutant BCM62 (2); col), imm+, Apr mutant B12-26-1 (3); col),
imm+, Apr mutant BCM25 (4); col), imm), Apr mutant BCM114
(5); col), imm+, Apr mutant BCM920 (6); D col, imm), Apr mutant
BCM147 (7); 8 col), imm+, Apr mutant BCM195; 9 col+, imm+,
Apr mutant B12-5-6; 10 col+, imm+, Apr mutant BCM213.
Molecular weight markers are indicated on the left side. The picture
is a composition of the same gel with exposure to X-ray ﬁlm for
12 h for lane 1 and 48 h for all the others
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